Publication

Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on β-amyloid plaque load in two transgenic APP/PS1 mouse models of Alzheimer’s disease

PLOS One 11(7):e0158205, 2016

Hansen HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, Schlumberger C, Jelsing J, Terwel D, Termont A, Pyke C, Knudsen LB, Vrang N.

Share this page

Resource Library

Related resources

Quantitative whole-brain 3D imaging of congophilic parenchymal and vascular amyloid plaque architecture in a transgenic mouse model of Alzheimer’s disease

The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer’s disease

Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model

Plaques in an adult mouse brain

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650